Current Issue
Application of Quality Risk Management to Process Validation
Robert Dream, Managing Director, HDR Company LLC
A Holistic Phase Appropriate Strategy for HCP-Limits and HCP Characterization
Dr. Markus Haindl, Global Head Gene Therapy Technical Research & Development, Roche Di...
Strategies for Extractable and Leachable Risk Assessment of Polymeric Single Use Systems U...
Ping Wang, Director, Johnson & Johnson
Use of Non-Contact Raman Spectroscopy to Derive Reaction Kinetics
Richard Hart, Senior Director – Head of Automation and Data Science (Previously Asso...
Amsphere A3
JSR Life Sciences
Featured Articles
Coupling single-pass TFF before loading onto a chromatography sorbent
Characterization and Engineering Performance of the Allegro™ STR 500 Single-Use Stirred Tank Bioreactor
Continuous Bioprocessing: PAT Strategies in Support of Process Monitoring and Control to Enable Rapid Product Release
By: Jeffrey Doyle, Manager, PAT Projects in the Process Analytical Sciences Group
Paul Jeffers, Manager, PAT Projects in Process Analytical Sciences Group, Global Technology Services
Seamus O’Neill, Analytical Chemist
Pfizer
Beyond Quality: PAT as a Catalyst for Carbon Reduction in Pharma
View All Featured ArticlesHeadline News
Onchilles reports early systemic activity with intratumoral N17350 in Phase I/II trial
Spruce separates CRHX-101 programme into new endocrinology company Adrenyx Biosciences
FDA grants Priority Review to BRUKINSA combination in first-line mantle cell lymphoma
Read All Headlines
Upcoming Webinars
View All Upcoming WebinarsPast Webinars
Using PAT to accelerate and optimize the process development of solid dosage forms.
Presented by Lizbeth Martinez, Ph. D. Associate Director Data Science, Oral Pharmaceutical Development at Novartis Basel Switzerland and Emiliano Genorini, Account Manager – MicroNIR at Viavi Solutions
04th November 2021
Cost Considerations for the Application of Continuous Processing
Presented by Narasimha Rao Nedunuri, CEO of CLONZ Biotech and Tania Pereira Chilima, Product Manager at Univercells
02nd October 2019
End User Perspective on Setting in-Process Endotoxin Limits
Presented by Dr Friedrich von Wintzingerode, Roche/Genentech
15th May 2018
View All Past Webinars
Featured Companies
View All Companies
Featured Video
At Pall we help you select the process model that’s perfect for you. Ensuring it’s adapted to meet your precise needs and assembled flawlessly, ready for the future, from day one.
View All Videos
Technical Papers
Amsphere A3 – protein A resin: an optimized media to minimize the impact of elution buffer selection
Strategy Emerging Markets for Risk Mitigation
Amsphere TM A3
Read All Technical Papers
Featured Products
Decrease Cleaning Validation Time and Resources
AdvantaPure
Amsphere™ A3 Protein A Resin – JSR Life Sciences
View All Products















